Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Rating) was the target of a large decrease in short interest in March. As of March 15th, there was short interest totalling 512,900 shares, a decrease of 31.4% from the February 28th total of 747,700 shares. Based on an average trading volume of 2,110,000 shares, the short-interest ratio is […]
Pioneer in Treating Dentofacial Abnormalities and / or Mild-to-Moderate Obstructive Sleep Apnea Ranks Among Top 10 Most Innovative Medical Device Companies.